Skip to main content
Clinical Trials/NCT03217539
NCT03217539
Completed
Not Applicable

The Two-County Swedish Mammography Screening Trial

Dalarna County Council, Sweden0 sites133,065 target enrollmentJuly 14, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Neoplasm Female
Sponsor
Dalarna County Council, Sweden
Enrollment
133065
Primary Endpoint
Breast cancer death
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Population-based randomized controlled trial carried out in two Swedish counties, Dalarna and Ostergotland to find out the impact of early detection on mortality from breast cancer.

Detailed Description

The Swedish Two-county study is a randomized controlled trial of invitation to mammography screening. The trial took place in Kopparberg (W), now called Dalarna, and Ostergotland counties in Sweden. The trial randomized 77,080 women aged 40-74 years to invitation to screening (active study population, ASP) and 55,985 women to no invitation to screening (passive study population, PSP). The trial started in 1977 in W-county and in 1978 in E-county. Women in age 40-49 years were invited to single-view mammography screening on average every 24 months, and women aged 50-74 years on average every 33 months. Approximately seven years after randomization a significant 31% decrease in breast cancer mortality was observed in the ASP group, whereupon the PSP was invited to screening once and the screening phase of the trial ended. The mortality data have been reported every two years during the follow-up period and published in peer-reviewed medical journals. The investigators have follow-up data to the Dec 31 2015. The 29-year follow-up data has been published in 2012 in Radiology. Publication of the long-term data reflects the fact that deaths avoided by early detection include some that would have occurred a considerable time later than the screening.

Registry
clinicaltrials.gov
Start Date
July 14, 2017
End Date
December 31, 2015
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Dalarna County Council, Sweden
Responsible Party
Principal Investigator
Principal Investigator

Laszlo Tabar, MD, FACR (Hon)

Emeritus Professor

Dalarna County Council, Sweden

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Breast cancer death

Time Frame: 9 years

Comparison of breast cancer mortality in the ASP versus PSP

Similar Trials